Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthias Eiber

Showing results (151-160 of 377) with videos related to

Pageof 38
Sort By:
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2013
PET/MR in prostate cancer: technical aspects and potential diagnostic valueMichael Souvatzoglou, Matthias Eiber, Axel Martinez-Moeller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2020
Early Prostate-Specific Antigen Changes and Clinical Outcome After <sup>177</sup>Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate CancerAndrei Gafita, Matthias M Heck, Isabel Rauscher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2019
Prostate-Specific Membrane Antigen-Guided SurgeryTobias Maurer, Markus Graefen, Henk van der Poel, et al.
Nature Reviews. Urology|January 16, 2019
Technologies for image-guided surgery for managing lymphatic metastases in prostate cancerFijs W B van Leeuwen, Alexander Winter, Henk G van Der Poel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 22, 2014
PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CTIsabel Rauscher, Matthias Eiber, Sebastian Fürst, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 22, 2011
Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWIMatthias Eiber, Konstantin Holzapfel, Carl Ganter, et al.
Cancers|July 24, 2021
Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?-An In Silico Study on the Role of Chronic Hypoxia in Prostate CancerGabriele Birindelli, Milos Drobnjakovic, Volker Morath, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
Matched-Pair Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non-Tumor-Related Uptake and Tumor PositivityMarkus Kroenke, Lilit Mirzoyan, Thomas Horn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 2016
First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid CancersTibor Vag, Carlos Gerngross, Peter Herhaus, et al.
BMC Cancer|November 20, 2014
Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancerDenys J Loeffelbein, Michael Souvatzoglou, Veronika Wankerl, et al.
Pageof 38

Showing results (151-160 of 377) with videos related to

Sort By:
Pageof 38
European Journal of Nuclear Medicine and Molecular Imaging|May 25, 2013
PET/MR in prostate cancer: technical aspects and potential diagnostic valueMichael Souvatzoglou, Matthias Eiber, Axel Martinez-Moeller, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 1, 2020
Early Prostate-Specific Antigen Changes and Clinical Outcome After <sup>177</sup>Lu-PSMA Radionuclide Treatment in Patients with Metastatic Castration-Resistant Prostate CancerAndrei Gafita, Matthias M Heck, Isabel Rauscher, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|November 17, 2019
Prostate-Specific Membrane Antigen-Guided SurgeryTobias Maurer, Markus Graefen, Henk van der Poel, et al.
Nature Reviews. Urology|January 16, 2019
Technologies for image-guided surgery for managing lymphatic metastases in prostate cancerFijs W B van Leeuwen, Alexander Winter, Henk G van Der Poel, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|March 22, 2014
PET/MR imaging in the detection and characterization of pulmonary lesions: technical and diagnostic evaluation in comparison to PET/CTIsabel Rauscher, Matthias Eiber, Sebastian Fürst, et al.
Journal of Magnetic Resonance Imaging : JMRI|April 22, 2011
Whole-body MRI including diffusion-weighted imaging (DWI) for patients with recurring prostate cancer: technical feasibility and assessment of lesion conspicuity in DWIMatthias Eiber, Konstantin Holzapfel, Carl Ganter, et al.
Cancers|July 24, 2021
Is Hypoxia a Factor Influencing PSMA-Directed Radioligand Therapy?-An In Silico Study on the Role of Chronic Hypoxia in Prostate CancerGabriele Birindelli, Milos Drobnjakovic, Volker Morath, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|December 5, 2020
Matched-Pair Comparison of <sup>68</sup>Ga-PSMA-11 and <sup>18</sup>F-rhPSMA-7 PET/CT in Patients with Primary and Biochemical Recurrence of Prostate Cancer: Frequency of Non-Tumor-Related Uptake and Tumor PositivityMarkus Kroenke, Lilit Mirzoyan, Thomas Horn, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|January 16, 2016
First Experience with Chemokine Receptor CXCR4-Targeted PET Imaging of Patients with Solid CancersTibor Vag, Carlos Gerngross, Peter Herhaus, et al.
BMC Cancer|November 20, 2014
Diagnostic value of retrospective PET-MRI fusion in head-and-neck cancerDenys J Loeffelbein, Michael Souvatzoglou, Veronika Wankerl, et al.
Pageof 38